VEGF serum levels are not associated with Parkinson's disease.
J
J
Infante
I
I
Mateo
E
E
Rodríguez-Rodríguez
J
J
Berciano
O
O
Combarros
D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D015984:Causality; D019610:Cytoprotection / Q000502:physiology*; D015536:Down-Regulation / Q000502:physiology; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009410:Nerve Degeneration / Q000378:metabolism / Q000503:physiopathology; D009474:Neurons / Q000378:metabolism; D010300:Parkinson Disease / Q000097:blood* / Q000503:physiopathology*; D011110:Polymorphism, Genetic / Q000235:genetics; D017678:Sex Distribution; D013378:Substantia Nigra / Q000378:metabolism / Q000503:physiopathology; D042461:Vascular Endothelial Growth Factor A / Q000097:blood* / Q000172:deficiency* / Q000235:genetics
D042461:Vascular Endothelial Growth Factor A